25.04.24 | Vollzeit | Wedel | An der Elbe&34Podcast reinpodcaster PlayerWas macht uns besonders?Die Alloheim-Unternehmensgruppe ist der führende Betreiber von rund 260 Pflegeeinrichtungen in Deutschland. Dieser Erfolg gebührt unseren 22.000 MitarbeiterInnen die sich für die Versorgung unserer BewohnerInnen einsetzen. Unsere tägliche Arbeit
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehen10.04.24 | Vollzeit | Wedel | Universitätsklinikum Hamburg-Eppendorf UKEInflammatory processes by AN converting ecto-nucleotidases and purinergic receptors, and (ii) AN-driven intracellular calcium and cAMP signaling in inflammation. The aim of this central service project Z02 is to produce 1) monoclonal antibodies and functional nanobodies against the main players of AN signaling
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Player in Wedel kostenlos abonnieren.